Skip to main content
OpenTrials
Completed

NCT Number: NCT03124017

Electronic Alert System for Improving Thromboprophylaxis in Hospitalized Medical Patients

The investigators aim to investigate whether a computer-based alert system in the electronic patient chart and order entry system using the Geneva Risk Score as clinical decision support tool to estimate the risk of venous thromboembolism improves the rate of appropriate thromboprophylaxis among hospitalized medical patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Venous Thromboembolism Cardiovascular Diseases Embolism and Thrombosis Thromboembolism Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Swiss Cardiovascular Center, Inselspital, University of Bern

Bern, 3010, Switzerland

About this study

The use of thromboprophylaxis among acutely ill hospitalized medical patients remains inconsistent. The present study aims to improve the use of appropriate thromboprophylaxis by implementing a computer-based alert system combined with a Geneva Risk Score calculation tool in the electronic patient chart and order entry system. Consecutive acutely ill medical patients without indication for therapeutic anticoagulation or ongoing therapeutic anticoagulant treatment admitted to the medical wards of the University Hospital Bern, Switzerland, will be randomized in a 1:1 fashion to the alert group in which an alert and the Geneva Risk Score calculation tool will be issued in the electronic patient chart or to the control group in which no alert will be issued. The primary endpoint is the rate of appropriate thromboprophylaxis during hospital stay.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Acutely ill medical patients admitted to medical wards

Exclusion criteria

  • Indication for therapeutic anticoagulation or ongoing therapeutic anticoagulant treatment

Treatment and study plan

Electronic alert and the Geneva Risk Score calculation tool issued in the electronic patient chart

Other

Primary outcomes

  1. Rate of appropriate thromboprophylaxis

    Time frame: During hospital stay (expected average duration of 1 week)

Secondary outcomes

  1. Use of the Geneva Risk Score calculation tool by the physician in charge

    Time frame: During hospital stay (expected average duration of 1 week)

  2. Rate of correct calculation of the Geneva Risk Score through the calculation tool by the physician in charge

    Time frame: During hospital stay (expected average duration of 1 week)

Sponsors and collaborators

Lead sponsor

Insel Gruppe AG, University Hospital Bern

Other

Registry information

Official study title

Electronic Alert System Combined With a Risk Score Calculation Tool for Improving Appropriate Thromboprophylaxis in Hospitalized Medical Patients: a Randomized Controlled Trial

Important dates

Study start
2015
Primary completion
2016
Study completion
2016
First posted
Apr 21, 2017
Registry last updated
Apr 21, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.